MedPath

Clinical study to assess the effectiveness of Khadir Vati in management of vaginal white discharge.

Not yet recruiting
Conditions
Other specified noninflammatory disorders of vagina. Ayurveda Condition: SOMAROGAH/SVETAPRADARAH,
Registration Number
CTRI/2023/01/049194
Lead Sponsor
PDEA College Of Ayurveda and Research Centre
Brief Summary

This study is randomised clinical study parallel group comparing efficacy of Khadir Vati 500 mg 2 tablets twice a day and Nagkeshar Vati 500 mg 2 tablets twice a day in the management of shwetpradar for 14 days in 64 patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
64
Inclusion Criteria

The patients having clinical signs and symptoms of Shwetpradara Yoni Kandu(Itching Vulva) Yoni Daha(Burning) Yoni Srava(Shwetpradar) Lower Abdominal Pain Low Backache.

Exclusion Criteria

Pregnant Women Any type of chronic systemic disorders-TB Cancer Patients consuming Oral Contraceptive Pills.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy of Khadir Vati and Nagkeshar vati follow up wise result before and after treatment in the management of Shwetpradar with help of Case Record Proforma and Clinical examination14 days treatment with two follow ups on 7th and 14th day
Secondary Outcome Measures
NameTimeMethod
To study the side effect of drugs if any14 days

Trial Locations

Locations (1)

Ayurved Rugnalay and Sterling Multispeciality Hospital Sector No 27 Nigdi Pune

🇮🇳

Pune, MAHARASHTRA, India

Ayurved Rugnalay and Sterling Multispeciality Hospital Sector No 27 Nigdi Pune
🇮🇳Pune, MAHARASHTRA, India
Nikita Sharadrao Mahajan
Principal investigator
7276564561
nikitamahajan4561@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.